The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression

Clin Transl Med. 2022 Feb;12(2):e654. doi: 10.1002/ctm2.654.

Abstract

Background: Tumour-associated macrophages (TAMs) play an important role in promoting the progression of pancreatic ductal adenocarcinoma (PDAC). Here, we aimed to study the epigenetic mechanisms in regulating pro-tumour M2-polarised TAMs in the PDAC tumour microenvironment.

Methods: This study was conducted based on ex vivo TAMs isolated from PDAC tissues and in vitro THP1-derived TAM model. RNA-sequencing (RNA-seq), assay for transposase-accessible chromatin with sequencing and chromatin immunoprecipitation sequencing were performed to investigate gene expression, chromatin accessibility, transcription factor binding sites and histone modifications. Gene knockdown in THP1-derived TAMs was performed with lentivirus, and the impact of THP1-derived TAMs on invasion and metastasis ability of PDAC cells were investigated with in vitro and in vivo functional assays. RNA-chromatin interaction was analysed by chromatin isolation through RNA purification with sequencing. RNA-protein interaction was studied by RNA immunoprecipitation and RNA pull-down.

Results: Our data showed that the transcription factor CTCF (CCCTC-binding factor) was highly expressed in TAMs and predicted to be significantly enriched in hyper-accessible chromatin regions when compared to monocytes. High infiltration of CTCF+ TAMs was significantly associated with poor prognosis in PDAC patients. Knockdown of CTCF in THP1-derived TAMs led to the down-regulation of specific markers for M2-polarised TAMs, including CD206 and CD163. When THP1-derived TAMs with CTCF knockdown, they showed a decreased ability of invasion and metastasis. Further integrative analysis of multi-omics data revealed that prostaglandin-endoperoxide synthase 2 (PTGS2) and PTGS2 antisense NF-κB1 complex-mediated expression regulator RNA (PACERR) were critical downstream targets of CTCF and positively correlated with each other, which are closely situated on a chromosome. Knockdown of PACERR exhibited a similar phenotype as observed in CTCF knockdown THP1-derived TAMs. Moreover, PACERR could directly bind to CTCF and recruit histone acetyltransferase E1A binding protein p300 to the promoter regions of PACERR and PTGS2, thereby enhancing histone acetylation and gene transcription, promoting the M2 polarization of TAMs in PDAC.

Conclusions: Our study demonstrated a novel epigenetic regulation mechanism of promoting pro-tumour M2-polarised TAMs in the PDAC tumour microenvironment.

Keywords: CTCF; E1A binding protein p300; Epigenetic mechanisms; LncRNA-PACERR; pancreatic ductal adenocarcinoma; prostaglandin-endoperoxide synthase 2; tumour-associated macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • CCCTC-Binding Factor / agonists
  • CCCTC-Binding Factor / biosynthesis
  • Carcinoma, Pancreatic Ductal / genetics*
  • Carcinoma, Pancreatic Ductal / metabolism
  • Cyclooxygenase 2 / drug effects*
  • Cyclooxygenase 2 / genetics
  • E1A-Associated p300 Protein / adverse effects*
  • E1A-Associated p300 Protein / metabolism
  • E1A-Associated p300 Protein / pharmacology
  • Female
  • Humans
  • Macrophages / metabolism*
  • Macrophages / physiology
  • Male
  • Middle Aged
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / genetics

Substances

  • CCCTC-Binding Factor
  • CTCF protein, human
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • E1A-Associated p300 Protein
  • EP300 protein, human